Home - Products - Others - Other Targets - 3,5-Diiodo-L-tyrosine dihydrate

3,5-Diiodo-L-tyrosine dihydrate

CAS No. 300-39-0

3,5-Diiodo-L-tyrosine dihydrate( —— )

Catalog No. M24224 CAS No. 300-39-0

3,5-Diiodo-L-tyrosine dihydrate is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 36 In Stock
1G 51 In Stock

Biological Information

  • Product Name
    3,5-Diiodo-L-tyrosine dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    3,5-Diiodo-L-tyrosine dihydrate is a natural product.
  • Description
    3,5-Diiodo-L-tyrosine dihydrate is a natural product.
  • In Vitro
    Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    300-39-0
  • Formula Weight
    432.98
  • Molecular Formula
    C9H9I2NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (115.48 mM)
  • SMILES
    NC(Cc(cc1I)cc(I)c1O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GRPP (human)

    GRPP (human) is a 30 amino acid Gcg-derived peptide. GRPP (human) causes slight increases in plasma insulin and decreases in plasma glucagon. GRPP (human) does not affect insulin secretion in rat islets.

  • Ilmetropium iodide

    Ilmetropium iodide is a bronchodilator.

  • Acetyl shikonin

    Acetylshikonin exhibits weak cytotoxicity against human umbilical vein endothelial cells (HUVECs) with IC5 of over 2 microM, exhibits the antiangiogenic and antitumorigenic effects by suppressing proliferation and angiogenic factors.